Jun 20, 2018
By Michael Kramer
A subsidiary of Ontario Power Generation is partnering with an American company – to produce the radioactive isotopes used to diagnose cancer, heart disease and other conditions.
The Crown corporation says CANDU reactors at its Darlington nuclear plant in Clarington – can produce molybdenum-99.. while still generating electricity.
Molybdenum-99 is needed to make the isotope technetium-99 for medical imaging.
Canada’s domestic supply of medical isotopes was disrupted – after the Chalk River reactor ceased production in 2016 – requiring hospitals to import the material from Europe, Africa and Australia.
Production at Darlington is expected to start by the end of 2019.
To learn about advertising opportunities with Zoomer Radio use the link below: